Valerie Jansen
Vermogen: - $ op 31-08-2026
Vermogen: - $ op 31-08-2026
Valerie Malyvanh Jansen is currently an Independent Director at OnKure Therapeutics, Inc. since 2024.
Former roles include Chief Medical Officer at Elevation Oncology, Inc. from 2021 to 2025 and Executive Medical Director at Mersana Therapeutics, Inc. from 2020 to 2021.
Education includes undergraduate studies at Maryville College, and doctorate degrees from The University of Tennessee Health Science Center and Pritzker School of Medicine.
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
-.--% | 07-08-2026 | 0 ( -.--% ) | - $ | 31-08-2026 |
| Bedrijven | Functie | Begin |
|---|
| Bedrijven | Functie | Einde |
|---|---|---|
| ELEN ONCO | Hoofd Techniek/Wetenschap/O&O | 31-03-2025 |
| MERSANA THERAPEUTICS | Hoofd Techniek/Wetenschap/O&O | 01-04-2021 |
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
| Bedrijven in privébezit | 5 |
|---|---|
Mersana Therapeutics, Inc.
Mersana Therapeutics, Inc. BiotechnologyHealth Technology Develops and manufactures antibody drug conjugates to improve patient outcomes in multiple oncology indications | Health Technology |
Maryville College
Maryville College Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
The University of Tennessee Health Science Center
The University of Tennessee Health Science Center Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Pritzker School of Medicine
Pritzker School of Medicine Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Elevation Oncology, Inc.
Elevation Oncology, Inc. BiotechnologyHealth Technology Develops elevating precision medicines for cancer treatment | Health Technology |
Kies jouw editie
Alle financiële informatie op nationaal niveau